FIELD: chemistry.
SUBSTANCE: in novel compounds of formula (I) HetAr represents pyrimidinyl or thiadiasolyl; R1 and R2 represent H; A represents C1-C2-alkyl; B represents aryl(CH2)0-3-O-C(O)-or arylcyclopropyl-C(O)-, in which aryl can be substituted with 1-5 substituents, each substituent represents C1-C4-alkyl. Invention also relates to pharmaceutical composition and to application of compounds of item 1. Obtaining novel compounds, as well as pharmaceutical composition possessing NMDA/NR2B antagonist activity.
EFFECT: increase of composition efficiency.
13 cl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
3,3-DIFLUOROPIPERIDINE CARBAMATE HETEROCYCLIC COMPOUNDS AS NR2B NMDA RECEPTOR ANTAGONISTS | 2016 |
|
RU2735277C2 |
AZAHETEROCYCLES COMPRISING FRAGMENT OF PIPERIDIN-2-YL- FOCUSED LIBRARIES AND PHARMACEUTICAL COMPOSITIONS | 2004 |
|
RU2259364C1 |
PYRIDINE DERIVATIVES USED AS QUICKLY DISSOCIABLE DOPAMINE RECEPTOR 2 ANTAGONISTS | 2008 |
|
RU2480462C2 |
SUBSTITUTED (2R,3R,5R)-3-HYDROXY-(5-PYRIMIDIN-1-YL)TETRAHYDROFURAN-2-YLMETHYL ARYL PHOSPHORAMIDATES | 2013 |
|
RU2553996C1 |
COMPOSITIONS CONTAINING BENZOPIPERAZINE AS BROMODOMAIN BET INHIBITORS | 2014 |
|
RU2720237C2 |
AMIDE DERIVATIVES OF CARBOXYLIC ACID, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF | 2001 |
|
RU2271361C2 |
PYRROLIDINE AND PIPERIDINE COMPOUNDS | 2020 |
|
RU2803455C1 |
INDAZOLE DERIVATIVE, METHOD FOR PREPARATION AND PHARMACEUTICAL USE THEREOF | 2020 |
|
RU2817737C2 |
NEW INHIBITORS OF SERINE-THREONINE KINASES, INCLUDING FOR TREATMENT OF ONCOLOGICAL DISEASES AND TUBERCULOSIS | 2016 |
|
RU2633032C1 |
DERIVATIVES OF TETRAHYDROISOQUINOLINE, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR INHIBITION OF SYNAPTIC UPTAKE OF DOPAMINE AND TREATMENT METHOD | 2000 |
|
RU2293728C2 |
Authors
Dates
2008-11-27—Published
2004-05-28—Filed